MIDAZOLAM HYDROCHLORIDE syrup Estats Units - anglès - NLM (National Library of Medicine)

midazolam hydrochloride syrup

major pharmaceuticals - midazolam hydrochloride (unii: w7ttw573jj) (midazolam - unii:r60l0sm5bc) - midazolam hcl syrup is indicated for use in pediatric patients for sedation, anxiolysis and amnesia prior to diagnostic, therapeutic or endoscopic procedures or before induction of anesthesia. midazolam hcl syrup is intended for use in monitored settings only and not for chronic or home use [see warnings]. midazolam hcl syrup is contraindicated in patients with a known hypersensitivity to the drug or allergies to cherries or formulation excipients. benzodiazepines are contraindicated in patients with acute narrow-angle glaucoma. benzodiazepines may be used in patients with open-angle glaucoma only if they are receiving appropriate therapy. measurements of intraocular pressure in patients without eye disease show a moderate lowering following induction of general anesthesia with injectable midazolam; patients with glaucoma have not been studied. midazolam hcl syrup is a benzodiazepine and is a schedule iv controlled substance that can produce drug dependence of the diazepam-type. therefore, midazolam hcl syrup

MIDAZOLAM HYDROCHLORIDE syrup Estats Units - anglès - NLM (National Library of Medicine)

midazolam hydrochloride syrup

major pharmaceuticals - midazolam hydrochloride (unii: w7ttw573jj) (midazolam - unii:r60l0sm5bc) - midazolam hcl syrup is indicated for use in pediatric patients for sedation, anxiolysis and amnesia prior to diagnostic, therapeutic or endoscopic procedures or before induction of anesthesia. midazolam hcl syrup is intended for use in monitored settings only and not for chronic or home use [see warnings]. midazolam hcl syrup is contraindicated in patients with a known hypersensitivity to the drug or allergies to cherries or formulation excipients. benzodiazepines are contraindicated in patients with acute narrow-angle glaucoma. benzodiazepines may be used in patients with open-angle glaucoma only if they are receiving appropriate therapy. measurements of intraocular pressure in patients without eye disease show a moderate lowering following induction of general anesthesia with injectable midazolam; patients with glaucoma have not been studied. midazolam hcl syrup is a benzodiazepine and is a schedule iv controlled substance that can produce drug dependence of the diazepam-type. therefore, midazolam hcl syrup

MIDAZOLAM HYDROCHLORIDE syrup Estats Units - anglès - NLM (National Library of Medicine)

midazolam hydrochloride syrup

american health packaging - midazolam hydrochloride (unii: w7ttw573jj) (midazolam - unii:r60l0sm5bc) - midazolam hcl syrup is indicated for use in pediatric patients for sedation, anxiolysis and amnesia prior to diagnostic, therapeutic or endoscopic procedures or before induction of anesthesia. midazolam hcl syrup is intended for use in monitored settings only and not for chronic or home use [see warnings]. midazolam hcl syrup is contraindicated in patients with a known hypersensitivity to the drug or allergies to cherries or formulation excipients. benzodiazepines are contraindicated in patients with acute narrow-angle glaucoma. benzodiazepines may be used in patients with open-angle glaucoma only if they are receiving appropriate therapy. measurements of intraocular pressure in patients without eye disease show a moderate lowering following induction of general anesthesia with injectable midazolam; patients with glaucoma have not been studied. midazolam hcl syrup is a benzodiazepine and is a schedule iv controlled substance that can produce drug dependence of the diazepam-type. therefore, midazolam hc

MIDAZOLAM injection Estats Units - anglès - NLM (National Library of Medicine)

midazolam injection

hikma pharmaceuticals usa inc. - midazolam hydrochloride (unii: w7ttw573jj) (midazolam - unii:r60l0sm5bc) - midazolam injection is indicated: - intramuscularly or intravenously for preoperative sedation/anxiolysis/amnesia; - intravenously as an agent for sedation/anxiolysis/amnesia prior to or during diagnostic, therapeutic or endoscopic procedures, such as bronchoscopy, gastroscopy, cystoscopy, coronary angiography, cardiac catheterization, oncology procedures, radiologic procedures, suture of lacerations and other procedures either alone or in combination with other cns depressants; - intravenously for induction of general anesthesia, before administration of other anesthetic agents. with the use of narcotic premedication, induction of anesthesia can be attained within a relatively narrow dose range and in a short period of time. intravenous midazolam can also be used as a component of intravenous supplementation of nitrous oxide and oxygen (balanced anesthesia); - continuous intravenous infusion for sedation of intubated and mechanically ventilated patients as a component of anesthesia or during treatment in a c

MIDAZOLAM injection Estats Units - anglès - NLM (National Library of Medicine)

midazolam injection

henry schein, inc. - midazolam hydrochloride (unii: w7ttw573jj) (midazolam - unii:r60l0sm5bc) - midazolam injection is indicated: - intramuscularly or intravenously for preoperative sedation/anxiolysis/amnesia; - intravenously as an agent for sedation/anxiolysis/amnesia prior to or during diagnostic, therapeutic or endoscopic procedures, such as bronchoscopy, gastroscopy, cystoscopy, coronary angiography, cardiac catheterization, oncology procedures, radiologic procedures, suture of lacerations and other procedures either alone or in combination with other cns depressants; - intravenously for induction of general anesthesia, before administration of other anesthetic agents. with the sue of narcotic premedications, induction of anesthesia can be attained within a relatively narrow dose range and in a short period of time. intravenous midazolam can also be used as a component of intravenous supplementation of nitrous oxide and oxygen (balanced anesthesia): - continuous intravenous infusion for sedation of intubated and mechanically ventilated patients as a component of anesthesia or during treatment in a

MIDAZOLAM injection, solution Estats Units - anglès - NLM (National Library of Medicine)

midazolam injection, solution

general injectables and vaccines, inc. - midazolam hydrochloride (unii: w7ttw573jj) (midazolam - unii:r60l0sm5bc) - midazolam injection is indicated: - intramuscularly or intravenously for preoperative sedation/anxiolysis/amnesia; - intravenously as an agent for sedation/anxiolysis/ amnesia prior to or during diagnostic, therapeutic or endoscopic procedures, such as bronchoscopy, gastroscopy, cystoscopy, coronary angiography, cardiac catheterization, oncology procedures, radiologic procedures, suture of lacerations and other procedures either alone or in combination with other cns depressants; - intravenously for induction of general anesthesia, before administration of other anesthetic agents. with the use of narcotic premedication, induction of anesthesia can be attained within a relatively narrow dose range and in a short period of time. intravenous midazolam can also be used as a component of intravenous supplementation of nitrous oxide and oxygen (balanced anesthesia); - continuous intravenous infusion for sedation of intubated and mechanically ventilated patients as a component of anesthesia or during treatment in a

MIDAZOLAM injection, solution Estats Units - anglès - NLM (National Library of Medicine)

midazolam injection, solution

hf acquisition co llc, dba healthfirst - midazolam hydrochloride (unii: w7ttw573jj) (midazolam - unii:r60l0sm5bc) - midazolam injection is indicated: intramuscularly or intravenously for preoperative sedation/anxiolysis/amnesia; intravenously as an agent for sedation/anxiolysis/amnesia prior to or during diagnostic, therapeutic or endoscopic procedures, such as bronchoscopy, gastroscopy, cystoscopy, coronary angiography, cardiac catheterization, oncology procedures, radiologic procedures, suture of lacerations and other procedures either alone or in combination with other cns depressants; intravenously for induction of general anesthesia, before administration of other anesthetic agents. with the use of narcotic premedication, induction of anesthesia can be attained within a relatively narrow dose range and in a short period of time. intravenous midazolam can also be used as a component of intravenous supplementation of nitrous oxide and oxygen (balanced anesthesia); continuous intravenous infusion for sedation of intubated and mechanically ventilated patients as a component of anesthesia or during treatment

ZYAMIS midazolam (as maleate) 5 mg/0.5 mL oromucosal solution pre-filled oral syringe Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

zyamis midazolam (as maleate) 5 mg/0.5 ml oromucosal solution pre-filled oral syringe

clinect pty ltd - midazolam maleate, quantity: 6.8 mg (equivalent: midazolam, qty 5 mg) - solution - excipient ingredients: ethanol; saccharin sodium; glycerol; purified water; sodium hydroxide; maltitol - zyamis, as buccal midazolam, is indicated for the treatment of generalised convulsive status epilepticus (gcse), in those over 6 months old.

ZYAMIS midazolam (as maleate) 2.5 mg/0.25 mL oromucosal solution pre-filled oral syringe Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

zyamis midazolam (as maleate) 2.5 mg/0.25 ml oromucosal solution pre-filled oral syringe

clinect pty ltd - midazolam maleate, quantity: 3.4 mg (equivalent: midazolam, qty 2.5 mg) - solution - excipient ingredients: ethanol; saccharin sodium; glycerol; purified water; sodium hydroxide; maltitol - zyamis, as buccal midazolam, is indicated for the treatment of generalised convulsive status epilepticus (gcse), in those over 6 months old.

ZYAMIS midazolam (as maleate) 10 mg/1 mL oromucosal solution pre-filled oral syringe Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

zyamis midazolam (as maleate) 10 mg/1 ml oromucosal solution pre-filled oral syringe

clinect pty ltd - midazolam maleate, quantity: 13.6 mg (equivalent: midazolam, qty 10 mg) - solution - excipient ingredients: ethanol; saccharin sodium; glycerol; purified water; sodium hydroxide; maltitol - zyamis, as buccal midazolam, is indicated for the treatment of generalised convulsive status epilepticus (gcse), in those over 6 months old.